Document is current
Any future updates will be listed below
-
Authors
Zeng, Yong https://orcid.org/0000-0001-5719-1272
Abelman, Dor D. https://orcid.org/0000-0002-6765-4733
Singhawansa, Althaf https://orcid.org/0009-0008-2985-4794
Cheng, Nicholas
Fang, Yuanchang
Main, Sasha C.
Bell, Emma
Ye, Wenbin
Luo, Ping
Wilson, Samantha L. https://orcid.org/0000-0003-4346-9696
Stutheit-Zhao, Eric Y.
Wong, Derek
Znassi, Nadia
Chen, Kui https://orcid.org/0009-0004-3366-9090
Mohanraj, Suluxan
Sanz-Garcia, Enrique https://orcid.org/0000-0002-3119-3832
Notta, Faiyaz https://orcid.org/0000-0002-5748-3985
Ghanekar, Anand
Awadalla, Philip
Lok, Benjamin H.
Hoffman, Michael M.
Kim, Raymond H. https://orcid.org/0000-0002-2147-8674
Zadeh, Gelareh https://orcid.org/0000-0002-6637-4502
De Carvalho, Daniel D.
Bratman, Scott V.
Lupien, Mathieu https://orcid.org/0000-0003-0929-9478
Pugh, Trevor J. https://orcid.org/0000-0002-8073-5888
He, Housheng Hansen https://orcid.org/0000-0003-2898-3363
- License Information
-
More Information
Article History
Received: 6 July 2024
Accepted: 9 January 2026
First Online: 19 February 2026
Competing interests
: S.V.B. declares stock ownership in Adela; a leadership position in Adela; patents licensed to Roche, Adela; and royalties from Roche. T.J.P. reports personal fees from AstraZeneca, Canadian Pension Plan Investment Board, Chrysalis Biomedical Advisors, Illumina, Merck, PACT Pharma and SAGA Diagnostics, and grants from Roche/Genentech outside the submitted work. B.H.L. reports grants from Pfizer and grants, personal fees and nonfinancial support from AstraZeneca and personal fees from Daiichi-Sankyo outside the submitted work. E.S.G. reports research funding from GSK and Rgenta, as well as consulting roles with GSK and Lutris. H.H.H. reports personal fees from Synth-Med outside the submitted work. S.L.W. and M.M.H. have a patent application licensed to Adela. E.Y.S.-Z. has provided consulting for Adela. N.Z. reports stock ownership and a leadership position in Otaksa. The other authors declare no competing interests.
